Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 4 Interventional Results available

Phase4/Symbicort® Versus Pulmicort Flexhaler® in African Americans

ClinicalTrials.gov ID: NCT00702325

Public ClinicalTrials.gov record NCT00702325. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 20, 2026, 4:51 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A 12-wk, Rand., Double-blind, Double Dummy, Multi-ctr., Phase IV Study Comparing Efficacy and Safety of SYMBICORT® pMDI 160/4.5 ug x 2 Actuations Twice Daily Versus Pulmicort® (Budesonide Inhalation Powder DPI) 180 ug x 2 Inhalations Twice Daily, in Adult and Adolescent African American Subjects With Asthma

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

To compare the efficacy of SYMBICORT® pMDI 160/4.5 μg x 2 actuations twice daily (bid) to that of budesonide inhalation powder DPI 180 μg x 2 inhalations bid, in African American(self-reported) subjects with inhaled corticosteroid (ICS) dependent asthma.

Study identification

NCT ID
NCT00702325
Recruitment status
Completed
Study type
Interventional
Phase
Phase 4
Lead sponsor
AstraZeneca
Industry
Enrollment
311 participants

Conditions and interventions

Eligibility (public fields only)

Age range
12 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Jun 2008 (Type not available)
Primary completion
Sep 2009 (Actual)
Completion
Sep 2009 (Actual)
Last update posted
Nov 9, 2012

2008 – 2009

United States locations

U.S. sites
57
U.S. states
22
U.S. cities
57
Facility City State ZIP Site status
Research Site Pell City Alabama — —
Research Site Bentonville Arkansas — —
Research Site Hot Springs Arkansas — —
Research Site Little Rock Arkansas — —
Research Site Malvern Arkansas — —
Research Site Huntington Park California — —
Research Site Long Beach California — —
Research Site Los Angeles California — —
Research Site Los Angles California — —
Research Site Orange California — —
Research Site Rolling Hills Estates California — —
Research Site Centennial Colorado — —
Research Site Colorado Springs Colorado — —
Research Site Waterbury Connecticut — —
Research Site Inverness Florida — —
Research Site Miami Florida — —
Research Site Ocala Florida — —
Research Site Tallahassee Florida — —
Research Site Tampa Florida — —
Research Site Alpharetta Georgia — —
Research Site Atlanta Georgia — —
Research Site Decatur Georgia — —
Research Site Lawrenceville Georgia — —
Research Site Lithia Springs Georgia — —
Research Site Lovejoy Georgia — —
Research Site Chicago Illinois — —
Research Site Hagerstown Maryland — —
Research Site Lanham Maryland — —
Research Site Largo Maryland — —
Research Site Towson Maryland — —
Research Site Flint Michigan — —
Research Site Kansas City Missouri — —
Research Site St Louis Missouri — —
Research Site Las Vegas Nevada — —
Research Site Skillman New Jersey — —
Research Site New York New York — —
Research Site North Syracuse New York — —
Research Site Durham North Carolina — —
Research Site Greenville North Carolina — —
Research Site Raleigh North Carolina — —
Research Site Portland Oregon — —
Research Site Blue Bell Pennsylvania — —
Research Site Charleston South Carolina — —
Research Site Spartanburg South Carolina — —
Research Site Memphis Tennessee — —
Research Site Arlington Texas — —
Research Site Dallas Texas — —
Research Site Fort Worth Texas — —
Research Site Houston Texas — —
Research Site McKinney Texas — —
Research Site Plano Texas — —
Research Site San Antonio Texas — —
Research Site Waco Texas — —
Research Site Emporia Virginia — —
Research Site Richmond Virginia — —
Research Site Virginia Beach Virginia — —
Research Site Milwaukee Wisconsin — —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00702325, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Nov 9, 2012 · Synced Oct 20, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT00702325 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →